The stock had risen 0.67% to Rs 75 on Monday, 24 November 2008, after the company.announced the acquisition after trading hours on Friday, 21 November 2008.Meanwhile, the BSE Sensex was up 22.79 points, or 0.26%, to 8,925.91.On BSE, 1.50 lakh shares were traded in the counter. The stock had an average daily volume of 2.69 lakh shares in the past one quarter.
The stock hit a high of Rs 80.90 and a low of Rs 76 so far during the day. The stock hit a 52-week high of Rs 127 on 8 January 2008 and a 52-week low of Rs 60 on 27 October 2008.
The mid-cap stock had outperformed the market over the past one month till 24 November 2008, gaining 4.82% as compared to the Sensex's decline of 2.32%. It had also outperformed the market in the past one quarter, declining 16.06% as compared to the Sensex's decline of 38.18%.
The company's current equity is Rs 86.51 crore. Face value per share is Rs 1.
The current price of Rs 80.45 discounts the company's Q2 September 2008 annualized EPS of Rs 4.95, by a PE multiple of 16.25.
The company has acquired 72.15% stake in Bombay Stock Exchange listed Fem Care Pharma for Rs 203.7 crore in an all cash deal. The acquisition is at a price of Rs 800 per share. Dabur India will make an open offer for an additional 20% stake in Fem Care Pharma as required under the takeover regulations.
Fem Care Pharma is a leading player in the women's skin care products market.
Dabur India's net profit rose 83.90% to Rs 5.50 crore on 46.7% increase in net sales to Rs 23.65 crore in Q2 September 2008 over Q2 September 2007.
The company is engaged in manufacturing health care, personal care and food products.
No comments:
Post a Comment